Literature DB >> 24457162

Who is at risk for having persistent insomnia symptoms? A longitudinal study in the general population in Korea.

Sooyeon Suh1, Hae-Chung Yang2, Christopher P Fairholme3, Hyun Kim4, Rachel Manber5, Chol Shin6.   

Abstract

OBJECTIVES: Our study had three goals: (1) to investigate the longitudinal course of insomnia symptoms over 4 years (3 time points) by analyzing the trajectory of insomnia symptoms for all participants, (2) to compare persistent insomnia symptom to nonpersistent insomnia symptom groups on mental health and quality of life (QoL), and (3) to conduct exploratory analyses on the relative contribution of multiple factors to persistence of insomnia symptoms.
METHODS: Our population-based longitudinal study utilized a community-based sample from the Korean Genome and Epidemiology study (KoGES). Participants were 1247 individuals (40.1% men; mean age, 54.3±7.1 years). Insomnia, QoL (measured by 12-item Short-Form health survey [SF-12]), sleep-interfering behaviors, and depression (measured by the Beck Depression Inventory [BDI]) were followed with biennial examinations at 3 data points spaced 2 years apart (baseline, time 1, and time 2).
RESULTS: Among individuals experiencing insomnia symptoms at baseline, the most common trajectory was to experience persistent nocturnal insomnia symptoms across all 3 time points. Those with persistent insomnia symptoms had significantly lower physical and mental QoL (measured by SF-12) and higher depression (measured by BDI) at time points compared to those without persistent nocturnal insomnia symptoms. A follow-up exploratory receiver operating characteristic curve (ROC) analysis identified poor sleep quality, frequent sleep-interfering behaviors, and low mental health QoL as the strongest predictors of persistent insomnia symptoms above other well-known risk factors.
CONCLUSIONS: In particular, an interaction between poor sleep quality, sleep-interfering behaviors, and mental health QoL appeared to be the strongest risk factor for persistent insomnia symptoms.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epidemiology; Insomnia; Longitudinal; Mental health; Quality of life; Sleep

Mesh:

Year:  2013        PMID: 24457162     DOI: 10.1016/j.sleep.2013.09.024

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  6 in total

1.  Racial/Ethnic Differences in Insomnia Trajectories Among U.S. Older Adults.

Authors:  Christopher N Kaufmann; Ramin Mojtabai; Rebecca S Hock; Roland J Thorpe; Sarah L Canham; Lian-Yu Chen; Alexandra M V Wennberg; Lenis P Chen-Edinboro; Adam P Spira
Journal:  Am J Geriatr Psychiatry       Date:  2016-02-23       Impact factor: 4.105

2.  The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study
.

Authors:  Nick Glozier; Tom J Moullaali; Børge Sivertsen; Dukyeon Kim; Gillian Mead; Stephen Jan; Qiang Li; Maree L Hackett
Journal:  Cerebrovasc Dis Extra       Date:  2017-02-03

3.  Is Metabolic Rate Increased in Insomnia Disorder? A Systematic Review.

Authors:  Julia L Chapman; Maria Comas; Camilla M Hoyos; Delwyn J Bartlett; Ronald R Grunstein; Christopher J Gordon
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-16       Impact factor: 5.555

Review 4.  Effects of sleep changes on pain-related health outcomes in the general population: A systematic review of longitudinal studies with exploratory meta-analysis.

Authors:  Esther F Afolalu; Fatanah Ramlee; Nicole K Y Tang
Journal:  Sleep Med Rev       Date:  2017-08-18       Impact factor: 11.609

5.  Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome.

Authors:  Seung Young Kim; Rok Seon Choung; Seung Ku Lee; Jung Wan Choe; Sung Woo Jung; Jong Jin Hyun; Ja Seol Koo; Sang Woo Lee; Chol Shin
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

6.  Incidence, Persistence, and Remission Rates of Insomnia Over 5 Years.

Authors:  Charles M Morin; Denise C Jarrin; Hans Ivers; Chantal Mérette; Mélanie LeBlanc; Josée Savard
Journal:  JAMA Netw Open       Date:  2020-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.